159 related articles for article (PubMed ID: 9851653)
1. Riluzole has no acute effect on motor unit parameters in ALS.
Desai J; Sharief M; Swash M
J Neurol Sci; 1998 Oct; 160 Suppl 1():S69-72. PubMed ID: 9851653
[TBL] [Abstract][Full Text] [Related]
2. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
Bellingham MC
CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
[TBL] [Abstract][Full Text] [Related]
3. Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Kovalchuk MO; Heuberger JAAC; Sleutjes BTHM; Ziagkos D; van den Berg LH; Ferguson TA; Franssen H; Groeneveld GJ
Clin Pharmacol Ther; 2018 Dec; 104(6):1136-1145. PubMed ID: 29672831
[TBL] [Abstract][Full Text] [Related]
4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
5. Riluzole and ALS therapy.
Hugon J
Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
[TBL] [Abstract][Full Text] [Related]
6. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
Cheah BC; Vucic S; Krishnan AV; Kiernan MC
Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
[TBL] [Abstract][Full Text] [Related]
7. Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole.
Albo F; Pieri M; Zona C
J Neurosci Res; 2004 Oct; 78(2):200-7. PubMed ID: 15378511
[TBL] [Abstract][Full Text] [Related]
8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
[TBL] [Abstract][Full Text] [Related]
9. Study protocol of RESCUE-ALS: A Phase 2,
Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT
BMJ Open; 2021 Jan; 11(1):e041479. PubMed ID: 33431491
[TBL] [Abstract][Full Text] [Related]
10. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Noto Y; Shibuya K; Vucic S; Kiernan MC
Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
[TBL] [Abstract][Full Text] [Related]
12. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2000; (2):CD001447. PubMed ID: 10796796
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
[TBL] [Abstract][Full Text] [Related]
15. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
16. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole.
Yáñez M; Galán L; Matías-Guiu J; Vela A; Guerrero A; García AG
Brain Res; 2011 Nov; 1423():77-86. PubMed ID: 21983205
[TBL] [Abstract][Full Text] [Related]
17. [Riluzole as a treatment for amyotrophic lateral sclerosis].
Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
[TBL] [Abstract][Full Text] [Related]
18. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis.
Gurney ME; Fleck TJ; Himes CS; Hall ED
Neurology; 1998 Jan; 50(1):62-6. PubMed ID: 9443458
[TBL] [Abstract][Full Text] [Related]
19. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
[TBL] [Abstract][Full Text] [Related]
20. Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole.
Bellingham MC
J Neurophysiol; 2013 Sep; 110(5):1047-61. PubMed ID: 23741042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]